Sauradeep Sarkar1, Sophy Korula2, Sarah Mathai2, Anna Simon2, Rajesh Balakrishnan3, Selvamani Backianathan3, Ari G Chacko4. 1. Department of Neurological Sciences, Christian Medical College, Vellore, 632004, India. sauradeepsarkar@gmail.com. 2. Department of Pediatric Endocrinology, Christian Medical College, Vellore, India. 3. Department of Radiation Oncology, Christian Medical College, Vellore, India. 4. Department of Neurological Sciences, Christian Medical College, Vellore, 632004, India.
Abstract
OBJECTIVE: Incomplete surgical removal of craniopharyngiomas frequently results in suboptimal oncological control. Radiation therapy is usually offered in these cases to prevent local recurrence of disease; however, the efficacy of radiation is limited by its potential adverse effect, particularly in younger patients. This study was undertaken to compare long-term outcomes and rates of postoperative obesity and endocrinopathy in patients undergoing either upfront adjuvant radiation after surgery, or postoperative surveillance with progression-contingent intervention. METHODS: Thirty-seven patients aged <25 years who had undergone primary incomplete surgical resection of craniopharyngiomas were retrospectively identified and categorized according to the prescribed treatment strategy. Recurrence rates, functional status, neuro-ophthalmologic, and endocrine outcomes were studied in both groups of patients. RESULTS: Twenty-three patients received upfront adjuvant radiation, and 14 patients underwent postoperative surveillance. Adjuvant radiation in the former group was delivered using either conventional (n=10), 3D-conformal (n=4), or fractionated stereotactic (n=9) techniques using a linear accelerator. The mean follow-up duration was 64.7 months (range 14-134 months). Disease progression was significantly higher in patients undergoing surveillance as compared to those undergoing upfront adjuvant radiation (71.4 versus 17.4%; p=0.002). Median progression-free survival times were 129 months and 27 months in the upfront adjuvant radiation and surveillance groups, respectively (p=0.007). In patients undergoing surveillance, 50% ultimately required irradiation, and the median radiation-free survival time in this subgroup was 57 months. Two children in the adjuvant radiation group developed asymptomatic radiation-related vasculopathies on follow-up; however, there were no statistically significant differences between the two groups in terms of visual, functional, or pituitary-hypothalamic function at last follow-up. CONCLUSIONS: In comparison to upfront adjuvant radiation following incomplete craniopharyngioma resection significantly, a strategy of postoperative surveillance resulted in less durable disease control but allowed radiation therapy to be delayed by a median time of 57 months, without significant detriment to global functional, visual, and neuro-endocrinological outcomes. The merits and demerits of either strategy should be carefully considered in the post-surgical management of these patients.
OBJECTIVE: Incomplete surgical removal of craniopharyngiomas frequently results in suboptimal oncological control. Radiation therapy is usually offered in these cases to prevent local recurrence of disease; however, the efficacy of radiation is limited by its potential adverse effect, particularly in younger patients. This study was undertaken to compare long-term outcomes and rates of postoperative obesity and endocrinopathy in patients undergoing either upfront adjuvant radiation after surgery, or postoperative surveillance with progression-contingent intervention. METHODS: Thirty-seven patients aged <25 years who had undergone primary incomplete surgical resection of craniopharyngiomas were retrospectively identified and categorized according to the prescribed treatment strategy. Recurrence rates, functional status, neuro-ophthalmologic, and endocrine outcomes were studied in both groups of patients. RESULTS: Twenty-three patients received upfront adjuvant radiation, and 14 patients underwent postoperative surveillance. Adjuvant radiation in the former group was delivered using either conventional (n=10), 3D-conformal (n=4), or fractionated stereotactic (n=9) techniques using a linear accelerator. The mean follow-up duration was 64.7 months (range 14-134 months). Disease progression was significantly higher in patients undergoing surveillance as compared to those undergoing upfront adjuvant radiation (71.4 versus 17.4%; p=0.002). Median progression-free survival times were 129 months and 27 months in the upfront adjuvant radiation and surveillance groups, respectively (p=0.007). In patients undergoing surveillance, 50% ultimately required irradiation, and the median radiation-free survival time in this subgroup was 57 months. Two children in the adjuvant radiation group developed asymptomatic radiation-related vasculopathies on follow-up; however, there were no statistically significant differences between the two groups in terms of visual, functional, or pituitary-hypothalamic function at last follow-up. CONCLUSIONS: In comparison to upfront adjuvant radiation following incomplete craniopharyngioma resection significantly, a strategy of postoperative surveillance resulted in less durable disease control but allowed radiation therapy to be delayed by a median time of 57 months, without significant detriment to global functional, visual, and neuro-endocrinological outcomes. The merits and demerits of either strategy should be carefully considered in the post-surgical management of these patients.
Authors: B C Wen; D H Hussey; J Staples; P W Hitchon; S K Jani; A P Vigliotti; J F Doornbos Journal: Int J Radiat Oncol Biol Phys Date: 1989-01 Impact factor: 7.038
Authors: A Pierre-Kahn; C Recassens; G Pinto; C Thalassinos; S Chokron; J C Soubervielle; R Brauner; M Zerah; C Sainte Rose Journal: Childs Nerv Syst Date: 2005-07-28 Impact factor: 1.475
Authors: A Leland Albright; Costas G Hadjipanayis; L Dade Lunsford; Douglas Kondziolka; Ian F Pollack; P David Adelson Journal: Childs Nerv Syst Date: 2005-06-02 Impact factor: 1.475
Authors: Maria Koutourousiou; Paul A Gardner; Juan C Fernandez-Miranda; Elizabeth C Tyler-Kabara; Eric W Wang; Carl H Snyderman Journal: J Neurosurg Date: 2013-08-02 Impact factor: 5.115
Authors: Lilie L Lin; Issam El Naqa; Jeffrey R Leonard; Tae Sung Park; Abby S Hollander; Jeff M Michalski; David B Mansur Journal: J Neurosurg Pediatr Date: 2008-02 Impact factor: 2.375
Authors: C J De Vile; D B Grant; B E Kendall; B G Neville; R Stanhope; K E Watkins; R D Hayward Journal: J Neurosurg Date: 1996-07 Impact factor: 5.115
Authors: Diana C H Stripp; Amit Maity; Anna J Janss; Jean B Belasco; Zelig A Tochner; Joel W Goldwein; Thomas Moshang; Lucy B Rorke; Peter C Phillips; Leslie N Sutton; Hui-Kuo G Shu Journal: Int J Radiat Oncol Biol Phys Date: 2004-03-01 Impact factor: 7.038